Home » Topics » Disease categories and therapies » Urology

Urology
RSS

OP-1 effective in renal failure

Nov. 15, 1996

Clinical trial program for RenaGel continues on schedule

Nov. 8, 1996

Synaptic, Merck extend BPH collaboration

Nov. 8, 1996

CV Therapeutics reports novel adenosine antagonist

Nov. 8, 1996

Potential use of phytopharmaceutical compounds for BPH

Nov. 1, 1996

Muscarinic antagonists from Yamanouchi

Oct. 25, 1996

New alternative available for BPH

Oct. 18, 1996

Merck persists in the search for BPH therapeutics

Oct. 18, 1996

Renal-urologic drugs in development at Yamanouchi

Oct. 11, 1996

Three renal-urologic drugs reported in the Fujisawa product pipeline

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...